Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
about
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artFood for thought: the role of appetitive peptides in age-related cognitive declineEffect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trialCSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseMetabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesCauses of metabolic syndrome and obesity-related co-morbidities Part 1: A composite unifying theory review of human-specific co-adaptations to brain energy consumption.Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models.Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedDysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's diseaseEarly intranasal insulin therapy halts progression of neurodegeneration: progress in Alzheimer's disease therapeutics.Relationships between diabetes and cognitive impairmentTargeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and MetabolomeH2O2 Signalling Pathway: A Possible Bridge between Insulin Receptor and Mitochondria.T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.Low-Molecular-Weight NGF Mimetic Corrects the Cognitive Deficit and Depression-like Behavior in Experimental Diabetes.The role of melatonin in the onset and progression of type 3 diabetes.Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis.Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.Clinical strategies for managing the overweight neurology patient.Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
P2860
Q26830845-C38FAB5C-734A-492D-BC74-0B2194221482Q27009988-B539E9DF-05CA-47A9-9494-315D1528CD11Q30559265-BD6220E6-F83E-4E4B-B258-38FE6C5A74F7Q33896118-B1EA244E-F96B-46CF-ACFC-C71242C6149BQ34288447-E590864E-7417-4055-8B2A-057D0B71B32FQ35104481-C7EE3DF3-9A13-4511-8440-AA352376CAB2Q35106896-86BC65D2-5F5F-4804-A1F0-4D05D665C5E3Q35925948-E7745BC9-4ED9-4EB1-91A9-CE5938A6F69FQ35997881-D34C09A6-F3BF-43BF-9717-F23504746BC9Q35997884-4D2A6600-7A9A-45F2-85FD-B6A41B2D2C9BQ36036789-72F148F4-E5D9-4735-98D0-696ABD88FE15Q36551193-8E3D20C7-C2C7-43C5-9C90-F44CA54693D7Q37162219-679843B2-B9F3-4FD9-81E3-1C3CECEFE0F0Q37164474-22C27AD6-1D5E-4A00-9696-ABF6A278A93BQ37685927-37D0E2E3-8D9B-4504-89F5-BF2E2FBC1B05Q38111372-09F99F7F-7534-4D49-913D-4E556D66CE89Q38396373-5A6F8A56-9DC6-4735-BA02-A2A7A71AEF00Q38663285-A248795D-BC32-4908-84B3-254184FC522CQ41206619-FD49A382-C840-4A6B-892E-4389F6B208B5Q42323524-ED9E8AB3-DEE1-4285-9B71-4C1216769F01Q46058400-AA28A47A-35CA-4BB9-9CC0-D4A17A35B179Q47122754-C381A048-F206-4B26-BDED-DD5B85D1D7B7Q47835103-84365C3A-F111-40DE-B2C8-D3EFF4DF1C03Q49724355-EDF311E6-B935-454B-AE7F-73DD828205E2Q58781043-35AADBCA-ADF4-43F9-A3C7-DAA299A7002F
P2860
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@ast
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@en
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@nl
type
label
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@ast
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@en
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@nl
prefLabel
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@ast
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@en
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@nl
P2860
P921
P1476
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
@en
P2093
de la Monte SM
P2860
P304
P407
P577
2012-01-01T00:00:00Z